Clinical Trial Update: A Phase I Open-Label, Single-Arm, Dose-Escalation Clinical and Pharmacology Study of CCI-001 as Monotherapy and in Combination With Standard Chemotherapy in Patients With Recurrent and/or Metastatic Solid Tumours [Phase 1]

View source ↗

Summary

This is a Phase 1 open-label, dose-escalation study evaluating CCI-001 as monotherapy and in combination with standard chemotherapy for patients with recurrent/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• CCI-001

Snippet

Sponsor: PharmaMatrix Holdings Ltd | Conditions: Cancer: Recurrent and/or Metastatic Solid Tumours | Phase 1 | Status: RECRUITING